Knowledge is power. Are you facing a new diagnosis or recurrence of Pancreatic Cancer? The GI Connection Pancreatic Cancer Information Center has current, evidence-based information for you. Get the facts about the prevention, treatment, and living with Pancreatic Cancer. Stay up to date with news, tips, and features designed to keep you informed about the most recent developments and advances. Learn more about Pancreatic Cancer.
You are not alone—The GI Connection Community is the leading Social Media Application for individuals seeking information, inspiration, and support. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs. Login or register here.
April 4, 2019
A new combination of immunotherapy and chemotherapy for pancreatic cancer caused tumors to shrink in the majority of evaluable patients […]
March 18, 2019
Lynparza (olaparib) improves progression-free survival (PFS) when used to treat BRCA-mutated pancreatic cancer and appears to represent a new treatment […]
February 28, 2019
Results from the trial showed a significant and clinically-meaningful improvement in progression-free survival (PFS) with Lynparza (olaparib) for the treatment […]
October 19, 2018
KETCHUM – LOS ANGELES: Laurie MacCaskill, a 12-year survivor of pancreatic cancer and former chair of the Pancreatic Cancer Action […]
June 19, 2018
The results of a recently presented clinical study at the American Society of Clinical Oncology meetings last week suggest that […]
April 18, 2018
CancerConnect News: The first interim analysis of the SEQUOIA clinical study evaluating the novel immunotherapy drug pegilodecakin in patients with […]
March 5, 2018
CancerConnect News: The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the anti-CTGF antibody, pamrevlumab, for […]